Successful second kidney transplantation following cured metastatic rectal cancer after first kidney transplantation, 20-year history: A case report

Chang-Hoon Lee, N. Lee, Eun-Kee Song, So-Yeon Jeon
{"title":"Successful second kidney transplantation following cured metastatic rectal cancer after first kidney transplantation, 20-year history: A case report","authors":"Chang-Hoon Lee, N. Lee, Eun-Kee Song, So-Yeon Jeon","doi":"10.1097/md9.0000000000000324","DOIUrl":null,"url":null,"abstract":"\n \n Solid organ transplant recipients face an elevated risk of malignancies due to immunosuppressive drugs and viral infections. Colorectal cancer is a common malignancy in kidney transplant (KT) recipients, with liver metastasis associated with worse. This case report highlights the successful resolution of colorectal cancer with liver metastasis following KT and subsequent triumph in a second KT after the cancer cure.\n \n \n \n A man who had undergone KT 10 years earlier presented with rectal bleeding. He was diagnosed with rectal cancer with no distant metastasis and recurrence of renal failure, with a creatinine level of 2 mg/dL.\n \n \n \n He underwent an anterior resection of a pathologic T3N0M0 tumor without risk features. Three months after surgery, a liver metastasis was detected, and a metastasectomy was performed. After the metastasectomy, the patient’s renal function further declined, and his creatinine levels increased from 5 mg/dL to over 12 mg/dL.\n \n \n \n A consultation to discuss adjuvant chemotherapy was postponed in favor of discussions regarding dialysis. He visited the oncologic clinic to discuss adjuvant treatment options 7 months post-metastasectomy. The decision was made to monitor for cancer recurrence without adjuvant therapy.\n \n \n \n The patient remained cancer-free for 5 years, and was declared cured. Another 6 years passed, and he achieved renal recovery through a second KT and maintained good health for the subsequent 2 years.\n \n \n \n Despite the poor prognosis for posttransplant malignancies, this case underscores the significance of early detection and tailored intervention in achieving successful outcomes for posttransplant malignancies and advocates for considering a second transplantation for cancer-cured patients experiencing organ function loss.\n","PeriodicalId":325445,"journal":{"name":"Medicine: Case Reports and Study Protocols","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine: Case Reports and Study Protocols","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/md9.0000000000000324","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Solid organ transplant recipients face an elevated risk of malignancies due to immunosuppressive drugs and viral infections. Colorectal cancer is a common malignancy in kidney transplant (KT) recipients, with liver metastasis associated with worse. This case report highlights the successful resolution of colorectal cancer with liver metastasis following KT and subsequent triumph in a second KT after the cancer cure. A man who had undergone KT 10 years earlier presented with rectal bleeding. He was diagnosed with rectal cancer with no distant metastasis and recurrence of renal failure, with a creatinine level of 2 mg/dL. He underwent an anterior resection of a pathologic T3N0M0 tumor without risk features. Three months after surgery, a liver metastasis was detected, and a metastasectomy was performed. After the metastasectomy, the patient’s renal function further declined, and his creatinine levels increased from 5 mg/dL to over 12 mg/dL. A consultation to discuss adjuvant chemotherapy was postponed in favor of discussions regarding dialysis. He visited the oncologic clinic to discuss adjuvant treatment options 7 months post-metastasectomy. The decision was made to monitor for cancer recurrence without adjuvant therapy. The patient remained cancer-free for 5 years, and was declared cured. Another 6 years passed, and he achieved renal recovery through a second KT and maintained good health for the subsequent 2 years. Despite the poor prognosis for posttransplant malignancies, this case underscores the significance of early detection and tailored intervention in achieving successful outcomes for posttransplant malignancies and advocates for considering a second transplantation for cancer-cured patients experiencing organ function loss.
首次肾移植治愈转移性直肠癌后成功进行第二次肾移植,20 年病史:病例报告
由于免疫抑制药物和病毒感染,实体器官移植受者罹患恶性肿瘤的风险较高。结直肠癌是肾移植(KT)受者中常见的恶性肿瘤,肝转移与病情恶化相关。本病例报告重点介绍了 KT 成功治愈伴有肝转移的结直肠癌,并在癌症治愈后成功进行了第二次 KT。 一名 10 年前接受过 KT 的男子出现直肠出血。他被诊断为直肠癌,无远处转移,肾功能衰竭复发,肌酐水平为 2 mg/dL。 他接受了无危险特征的病理 T3N0M0 肿瘤前切除术。术后三个月,发现肝脏转移,遂行转移灶切除术。转移灶切除术后,患者的肾功能进一步下降,肌酐水平从5毫克/分升升至12毫克/分升以上。 为了讨论透析问题,讨论辅助化疗的会诊被推迟了。肿瘤切除术后 7 个月,他来到肿瘤诊所讨论辅助治疗方案。最终决定在不进行辅助治疗的情况下监测癌症复发。 患者在 5 年的时间里一直未患癌症,并被宣布治愈。又过了 6 年,他通过第二次 KT 实现了肾功能恢复,并在随后的 2 年中保持了良好的健康状况。 尽管移植后恶性肿瘤的预后较差,但这一病例强调了早期发现和有针对性的干预对于移植后恶性肿瘤取得成功结果的重要意义,并主张考虑对器官功能丧失的癌症治愈患者进行第二次移植。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信